Automated Liquid Handling Market Size, Share, Industry Trends Segmentation Analysis by Type (Automat...

Report ID: | No. of Pages: | Base Year for Estimate: | Format: Report available in PDF formatReport available in PDF format

Automated Liquid Handling Market Size, Share, Industry Trends Segmentation Analysis by Type (Automated Workstations, Pipetting Systems, Reagents & Consumables, Software & Services) by Application (Drug Discovery, Genomics, Clinical Diagnostics, Proteomics, Cell Biology) Growth, demand, Regional Outlook, and Forecast 2025-2033

Price range: $3,499.00 through $5,499.00

The global Automated Liquid Handling Market size was valued at US$ 1.34 Billion in 2025 and is poised to grow from US$ 1.44 Billion in 2026 to 3.08 Billion by 2033, growing at a CAGR of 8% in the forecast period (2026-2033)

$3,499.00
$4,499.00
$5,499.00

Description

Automated Liquid Handling Market Overview

The global Automated Liquid Handling Market, which is a vital component of laboratory automation, offers high-precision solutions for the transfer, dispensing, and sampling of liquids across various scientific fields. This sector is currently evolving from basic robotic pipetting to fully integrated, “walk-away” laboratory ecosystems that facilitate high-throughput experimentation with minimal human involvement. The market acts as the essential infrastructure for contemporary life sciences, allowing for the rapid advancement of genomic research, drug discovery, and clinical diagnostics.

Current trends indicate a strategic transition towards modular and scalable workstations, enabling laboratories to tailor platforms with interchangeable pipetting heads and sensor-based liquid level detection. The market is experiencing a significant shift towards non-contact dispensing technologies, such as acoustic and piezoelectric mechanisms, which promote the miniaturization of assays and decrease the use of costly reagents. The incorporation of AI-driven software and IoT connectivity is becoming increasingly important, allowing for real-time remote monitoring, predictive maintenance, and autonomous error correction. There is also a marked increase in the adoption of automated workstations for next-generation sequencing (NGS), where accuracy in library preparation is crucial. The industry is also witnessing a growing emphasis on sustainability, highlighted by the creation of systems that reduce plastic consumable waste and enhance reagent usage through precise nanoliter-scale dispensing.

The global Automated Liquid Handling Market size was valued at US$ 1.34 Billion in 2025 and is poised to grow from US$ 1.44 Billion in 2026 to 3.08 Billion by 2033, growing at a CAGR of 8% in the forecast period (2026-2033)

Automated Liquid Handling Market Impact on Industry

The automated liquid handling market is fundamentally transforming biotechnology and clinical research by transitioning the laboratory model from manual, labor-intensive methods to high-speed, standardized workflows. Its most notable effect is seen in the genomics and drug discovery fields, where the capability to handle extensive sample libraries with complete accuracy has expedited the shift from molecular screening to clinical trial stages. By removing the inherent variability associated with human pipetting, these systems guarantee that intricate assays, such as next-generation sequencing library preparation and high-throughput drug screening, achieve a level of reproducibility that was previously impossible. This industrial advancement enables organizations to shorten research timelines, significantly decreasing the “time-to-market” for life-saving treatments while concurrently reducing the operational expenses linked to reagent waste and experimental repetitions.

Beyond technical efficiency, the market is having a transformative effect on workforce dynamics and laboratory safety. The incorporation of robotic handlers has effectively reduced the risk of repetitive strain injuries and minimized human exposure to hazardous or infectious biological materials, promoting a safer and more ergonomic working environment. This transition is empowering scientists to move away from monotonous, repetitive tasks and towards data-driven decision-making and experimental design, thereby enhancing the intellectual productivity of the contemporary laboratory. The implementation of “walk-away” automation allows laboratories to function continuously beyond standard working hours, creating a more resilient healthcare infrastructure capable of swiftly responding to public health crises. As a result, the industry is experiencing a movement towards fully integrated digital ecosystems, where automated hardware is seamlessly connected with laboratory information management systems to ensure comprehensive data traceability and integrity.

Automated Liquid Handling Market Dynamics:

Automated Liquid Handling Market Drivers

The main driving force behind the automated liquid handling market is the increasing demand for high-throughput screening (HTS) in drug discovery. Pharmaceutical laboratories are striving to expedite the identification of therapeutic candidates by processing millions of molecular compounds with both speed and precision. This trend is further supported by a systemic shift towards large-scale genomic and proteomic research, where the intricate nature of next-generation sequencing (NGS) library preparation requires automated solutions to handle nanoliter-scale liquid transfers without the risk of human error. The market is fueled by the pressing need for swift sample analysis in clinical and pre-clinical studies, especially as the global prevalence of chronic diseases and the rise of new viral threats lead to an increased volume of diagnostic testing. The heightened focus on laboratory safety and contamination control serves as a crucial driver, as automation reduces human interaction with hazardous or infectious biological samples, thereby ensuring a sterile and ergonomic working environment. The growing implementation of “walk-away” operations in centralized diagnostic hubs fosters market growth, enabling facilities to function continuously with minimal manual supervision to satisfy stringent turnaround time demands.

Challenges

A major challenge within the industry is the heightened “Operational and Programming Complexity”; these advanced workstations frequently necessitate specialized technical knowledge for configuration, troubleshooting, and integration into current laboratory information management systems (LIMS). This issue is exacerbated by the “Lack of Standardization in Liquid Classes”, as the differing viscosities and surface tensions of reagents can result in inconsistent dispensing volumes unless the systems are carefully calibrated for each distinct chemical property. Moreover, the industry contends with the ongoing threat of “Cross-Contamination and Splatter” during rapid gantry movements, where the swift aspiration and ejection of organic or slippery reagents may cause unintended droplet transfer between samples. The market also faces the “Difficulty in Reconfiguring Workflows” for specialized or low-volume protocols, as the inflexible nature of automated scripts can deter implementation in highly specialized research environments that require manual adaptability. Additionally, the lack of qualified automation engineers and trained laboratory staff presents a significant risk, especially in emerging markets where the shift from manual pipetting is impeded by insufficient technical support and training resources.

Opportunities

A major opportunity lies in the growth of “Sustainability-Focused Automation”, where manufacturers create energy-efficient workstations and enhance reagent-saving protocols to reduce the environmental impact of laboratory plastic waste. There is a considerable potential for expansion in the widespread implementation of “Miniaturized Process Equipment”, which allows laboratories to conduct intricate assays in ultra-low volumes, thereby significantly lowering costs associated with rare or expensive reagents. The rise of “Automated Liquid Handling for Cell and Gene Therapy” presents a profitable avenue, as the delicate nature of living cell cultures necessitates the accurate, sterile, and repeatable handling capabilities that only sophisticated robotic systems can offer. The incorporation of “Digital Twin and Remote Diagnostics” functionalities provides a distinctive opportunity, enabling laboratory managers to simulate and refine liquid handling protocols in a virtual setting prior to execution, thus mitigating the risk of sample loss. The application of “Point-of-Care and Portable Automation” for field research also presents a scalable growth opportunity, as compact and durable liquid handlers facilitate high-precision diagnostic testing in remote areas where conventional laboratory facilities are not accessible.

The Automated Liquid Handling Market Key Players: –

  • GBC Scientific Equipment
  • GERSTEL GmbH & Co. KG
  • GE Healthcare Life Sciences
  • Gilson
  • Hamilton Company
  • Hitachi
  • iChrom
  • PerkinElmer Inc.
  • Thermo Fisher Scientific
  • SPT Labtech
  • Shimadzu Scientific
  • QIAGEN NV.
  • Agilent
  • Anton-Paar
  • Analytik Jena
  • Aurora Biomed
  • Elemental Scientific
  • Distek
  • Ellutia
  • Fritsch International
  • EST Analytical

Recent Development:-

Taicang, China July 2, 2025 PerkinElmer officially inaugurated its expanded manufacturing and R&D facility in Taicang Suzhou, Jiangsu Province today. This milestone marks a significant advancement in the company’s “In China, For China and Beyond” strategy, reinforcing its long-term commitment to the Chinese market.

October 30, 2025 GERMANTOWN, Md. & VENLO, Netherlands (BUSINESS WIRE) QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution for processing sexual assault samples, at the upcoming International Symposium on Human Identification 2025 (ISHI) from November 3-6 in Palm Beach, Florida.

Automated Liquid Handling Market Regional Analysis: –

The global market for automated liquid handling systems is structured geographically, with North America leading in technology and the Asia-Pacific region undergoing rapid industrial modernization. By 2025, the market is realistically estimated to be valued between $1.34 billion and $3.07 billion, with long-term forecasts suggesting a valuation ranging from $3.08 billion to $8.64 billion by 2033-2035. This growth trajectory is bolstered by a global compound annual growth rate (CAGR) of approximately 8% to 11.2%, as laboratories around the world focus on minimizing errors and enhancing high-throughput capabilities in genomics and drug discovery.

North America maintains a leading role in the global market, holding a revenue share of about 39.87% to 44% in 2025. The regional market is expected to grow at a consistent CAGR of 8.11% to 8.5% through 2033. This leadership is largely attributed to the United States, which acts as a global center for biopharmaceutical research and venture-funded life science startups. The North American market is noted for its high adoption of “fully integrated” workstations, a trend driven by the necessity to mitigate high labor costs and the presence of major industry players such as Thermo Fisher Scientific and Danaher. Additionally, the region’s dominance is further supported by substantial NIH funding for genomic research and a strong infrastructure for clinical diagnostics, where automated liquid handlers play a crucial role in processing large volumes of patient samples.

The Asia-Pacific region is recognized as the fastest-growing market globally, demonstrating a strong compound annual growth rate (CAGR) ranging from 10.82% to 12.2% throughout the forecast period. By the year 2025, this region is anticipated to capture a substantial revenue share estimated between 21.4% and 25%, with its market valuation projected to more than double over the next ten years. This swift growth is driven by the vigorous modernization of healthcare infrastructure in both China and India, coupled with an increasing number of Contract Research Organizations (CROs) establishing operations in the area. Notably, China is experiencing a notable increase in the domestic production of automation tools, while the wider region benefits from government initiatives aimed at localizing pharmaceutical manufacturing. The CAGR for China is frequently highlighted as the key driver of the region, often surpassing 13% as local laboratories shift from manual pipetting methods to standardized robotic systems to comply with global quality standards.

Europe holds a robust strategic position, representing approximately 25% to 30% of the market share by 2025, with a forecasted CAGR of 8.35% to 9.1% extending into the early 2030s. Germany, the United Kingdom, and France are at the forefront of the European market, placing significant emphasis on the integration of liquid handling systems within personalized medicine and oncology research. The market in this region is characterized by a strong focus on sustainability and waste reduction, compelling manufacturers to innovate systems that enhance reagent efficiency and employ fixed-tip technology to reduce plastic waste. Concurrently, the Middle East & Africa (MEA) and Latin America are emerging as regions with considerable growth potential. The MEA area is projected to experience a CAGR of 7.6% to 8.2%, propelled by the growth of diagnostic laboratory networks and biobanking initiatives in the Gulf Cooperation Council (GCC) nations. Latin America is expected to follow closely with a projected CAGR of 7.2% to 7.8%, as major urban centers in Brazil and Mexico upgrade their clinical testing infrastructures to tackle the increasing prevalence of chronic infectious and metabolic diseases.

Automated Liquid Handling Market Segmentation:        

By Product Type

  • Automated Liquid Handling Workstations
    • Integrated Workstations
    • Standalone Workstations
  • Automated Pipetting Systems
  • Reagent Dispensers
  • Microplate Washers
  • Microplate Readers
  • Other Accessories (Software, Consumables, Grippers)

By Modality                                                                                

  • Disposable Tip Systems
  • Fixed Tip Systems

By Technology

  • Air Displacement Technology
  • Positive Displacement Technology
  • Acoustic Liquid Handling
  • Pressure-based Systems

By Application

  • Drug Discovery and Development
    • High-Throughput Screening
    • Lead Optimization
  • Genomics and Proteomics
    • Next-Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • DNA/RNA Purification
  • Clinical Diagnostics
    • Sample Preparation
    • Immunoassays
  • Cell Biology and Tissue Culture
    • Cell-based Assays
    • Stem Cell Research
  • Biobanking and Bioprocessing

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories
  • Forensic Laboratories

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Additional information

Variations

1, Corporate User, Multi User, Single User

Automated Liquid Handling Market Overview

The global Automated Liquid Handling Market, which is a vital component of laboratory automation, offers high-precision solutions for the transfer, dispensing, and sampling of liquids across various scientific fields. This sector is currently evolving from basic robotic pipetting to fully integrated, “walk-away” laboratory ecosystems that facilitate high-throughput experimentation with minimal human involvement. The market acts as the essential infrastructure for contemporary life sciences, allowing for the rapid advancement of genomic research, drug discovery, and clinical diagnostics.

Current trends indicate a strategic transition towards modular and scalable workstations, enabling laboratories to tailor platforms with interchangeable pipetting heads and sensor-based liquid level detection. The market is experiencing a significant shift towards non-contact dispensing technologies, such as acoustic and piezoelectric mechanisms, which promote the miniaturization of assays and decrease the use of costly reagents. The incorporation of AI-driven software and IoT connectivity is becoming increasingly important, allowing for real-time remote monitoring, predictive maintenance, and autonomous error correction. There is also a marked increase in the adoption of automated workstations for next-generation sequencing (NGS), where accuracy in library preparation is crucial. The industry is also witnessing a growing emphasis on sustainability, highlighted by the creation of systems that reduce plastic consumable waste and enhance reagent usage through precise nanoliter-scale dispensing.

The global Automated Liquid Handling Market size was valued at US$ 1.34 Billion in 2025 and is poised to grow from US$ 1.44 Billion in 2026 to 3.08 Billion by 2033, growing at a CAGR of 8% in the forecast period (2026-2033)

Automated Liquid Handling Market Impact on Industry

The automated liquid handling market is fundamentally transforming biotechnology and clinical research by transitioning the laboratory model from manual, labor-intensive methods to high-speed, standardized workflows. Its most notable effect is seen in the genomics and drug discovery fields, where the capability to handle extensive sample libraries with complete accuracy has expedited the shift from molecular screening to clinical trial stages. By removing the inherent variability associated with human pipetting, these systems guarantee that intricate assays, such as next-generation sequencing library preparation and high-throughput drug screening, achieve a level of reproducibility that was previously impossible. This industrial advancement enables organizations to shorten research timelines, significantly decreasing the “time-to-market” for life-saving treatments while concurrently reducing the operational expenses linked to reagent waste and experimental repetitions.

Beyond technical efficiency, the market is having a transformative effect on workforce dynamics and laboratory safety. The incorporation of robotic handlers has effectively reduced the risk of repetitive strain injuries and minimized human exposure to hazardous or infectious biological materials, promoting a safer and more ergonomic working environment. This transition is empowering scientists to move away from monotonous, repetitive tasks and towards data-driven decision-making and experimental design, thereby enhancing the intellectual productivity of the contemporary laboratory. The implementation of “walk-away” automation allows laboratories to function continuously beyond standard working hours, creating a more resilient healthcare infrastructure capable of swiftly responding to public health crises. As a result, the industry is experiencing a movement towards fully integrated digital ecosystems, where automated hardware is seamlessly connected with laboratory information management systems to ensure comprehensive data traceability and integrity.

Automated Liquid Handling Market Dynamics:

Automated Liquid Handling Market Drivers

The main driving force behind the automated liquid handling market is the increasing demand for high-throughput screening (HTS) in drug discovery. Pharmaceutical laboratories are striving to expedite the identification of therapeutic candidates by processing millions of molecular compounds with both speed and precision. This trend is further supported by a systemic shift towards large-scale genomic and proteomic research, where the intricate nature of next-generation sequencing (NGS) library preparation requires automated solutions to handle nanoliter-scale liquid transfers without the risk of human error. The market is fueled by the pressing need for swift sample analysis in clinical and pre-clinical studies, especially as the global prevalence of chronic diseases and the rise of new viral threats lead to an increased volume of diagnostic testing. The heightened focus on laboratory safety and contamination control serves as a crucial driver, as automation reduces human interaction with hazardous or infectious biological samples, thereby ensuring a sterile and ergonomic working environment. The growing implementation of “walk-away” operations in centralized diagnostic hubs fosters market growth, enabling facilities to function continuously with minimal manual supervision to satisfy stringent turnaround time demands.

Challenges

A major challenge within the industry is the heightened “Operational and Programming Complexity”; these advanced workstations frequently necessitate specialized technical knowledge for configuration, troubleshooting, and integration into current laboratory information management systems (LIMS). This issue is exacerbated by the “Lack of Standardization in Liquid Classes”, as the differing viscosities and surface tensions of reagents can result in inconsistent dispensing volumes unless the systems are carefully calibrated for each distinct chemical property. Moreover, the industry contends with the ongoing threat of “Cross-Contamination and Splatter” during rapid gantry movements, where the swift aspiration and ejection of organic or slippery reagents may cause unintended droplet transfer between samples. The market also faces the “Difficulty in Reconfiguring Workflows” for specialized or low-volume protocols, as the inflexible nature of automated scripts can deter implementation in highly specialized research environments that require manual adaptability. Additionally, the lack of qualified automation engineers and trained laboratory staff presents a significant risk, especially in emerging markets where the shift from manual pipetting is impeded by insufficient technical support and training resources.

Opportunities

A major opportunity lies in the growth of “Sustainability-Focused Automation”, where manufacturers create energy-efficient workstations and enhance reagent-saving protocols to reduce the environmental impact of laboratory plastic waste. There is a considerable potential for expansion in the widespread implementation of “Miniaturized Process Equipment”, which allows laboratories to conduct intricate assays in ultra-low volumes, thereby significantly lowering costs associated with rare or expensive reagents. The rise of “Automated Liquid Handling for Cell and Gene Therapy” presents a profitable avenue, as the delicate nature of living cell cultures necessitates the accurate, sterile, and repeatable handling capabilities that only sophisticated robotic systems can offer. The incorporation of “Digital Twin and Remote Diagnostics” functionalities provides a distinctive opportunity, enabling laboratory managers to simulate and refine liquid handling protocols in a virtual setting prior to execution, thus mitigating the risk of sample loss. The application of “Point-of-Care and Portable Automation” for field research also presents a scalable growth opportunity, as compact and durable liquid handlers facilitate high-precision diagnostic testing in remote areas where conventional laboratory facilities are not accessible.

The Automated Liquid Handling Market Key Players: –

  • GBC Scientific Equipment
  • GERSTEL GmbH & Co. KG
  • GE Healthcare Life Sciences
  • Gilson
  • Hamilton Company
  • Hitachi
  • iChrom
  • PerkinElmer Inc.
  • Thermo Fisher Scientific
  • SPT Labtech
  • Shimadzu Scientific
  • QIAGEN NV.
  • Agilent
  • Anton-Paar
  • Analytik Jena
  • Aurora Biomed
  • Elemental Scientific
  • Distek
  • Ellutia
  • Fritsch International
  • EST Analytical

Recent Development:-

Taicang, China July 2, 2025 PerkinElmer officially inaugurated its expanded manufacturing and R&D facility in Taicang Suzhou, Jiangsu Province today. This milestone marks a significant advancement in the company’s “In China, For China and Beyond” strategy, reinforcing its long-term commitment to the Chinese market.

October 30, 2025 GERMANTOWN, Md. & VENLO, Netherlands (BUSINESS WIRE) QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution for processing sexual assault samples, at the upcoming International Symposium on Human Identification 2025 (ISHI) from November 3-6 in Palm Beach, Florida.

Automated Liquid Handling Market Regional Analysis: –

The global market for automated liquid handling systems is structured geographically, with North America leading in technology and the Asia-Pacific region undergoing rapid industrial modernization. By 2025, the market is realistically estimated to be valued between $1.34 billion and $3.07 billion, with long-term forecasts suggesting a valuation ranging from $3.08 billion to $8.64 billion by 2033-2035. This growth trajectory is bolstered by a global compound annual growth rate (CAGR) of approximately 8% to 11.2%, as laboratories around the world focus on minimizing errors and enhancing high-throughput capabilities in genomics and drug discovery.

North America maintains a leading role in the global market, holding a revenue share of about 39.87% to 44% in 2025. The regional market is expected to grow at a consistent CAGR of 8.11% to 8.5% through 2033. This leadership is largely attributed to the United States, which acts as a global center for biopharmaceutical research and venture-funded life science startups. The North American market is noted for its high adoption of “fully integrated” workstations, a trend driven by the necessity to mitigate high labor costs and the presence of major industry players such as Thermo Fisher Scientific and Danaher. Additionally, the region’s dominance is further supported by substantial NIH funding for genomic research and a strong infrastructure for clinical diagnostics, where automated liquid handlers play a crucial role in processing large volumes of patient samples.

The Asia-Pacific region is recognized as the fastest-growing market globally, demonstrating a strong compound annual growth rate (CAGR) ranging from 10.82% to 12.2% throughout the forecast period. By the year 2025, this region is anticipated to capture a substantial revenue share estimated between 21.4% and 25%, with its market valuation projected to more than double over the next ten years. This swift growth is driven by the vigorous modernization of healthcare infrastructure in both China and India, coupled with an increasing number of Contract Research Organizations (CROs) establishing operations in the area. Notably, China is experiencing a notable increase in the domestic production of automation tools, while the wider region benefits from government initiatives aimed at localizing pharmaceutical manufacturing. The CAGR for China is frequently highlighted as the key driver of the region, often surpassing 13% as local laboratories shift from manual pipetting methods to standardized robotic systems to comply with global quality standards.

Europe holds a robust strategic position, representing approximately 25% to 30% of the market share by 2025, with a forecasted CAGR of 8.35% to 9.1% extending into the early 2030s. Germany, the United Kingdom, and France are at the forefront of the European market, placing significant emphasis on the integration of liquid handling systems within personalized medicine and oncology research. The market in this region is characterized by a strong focus on sustainability and waste reduction, compelling manufacturers to innovate systems that enhance reagent efficiency and employ fixed-tip technology to reduce plastic waste. Concurrently, the Middle East & Africa (MEA) and Latin America are emerging as regions with considerable growth potential. The MEA area is projected to experience a CAGR of 7.6% to 8.2%, propelled by the growth of diagnostic laboratory networks and biobanking initiatives in the Gulf Cooperation Council (GCC) nations. Latin America is expected to follow closely with a projected CAGR of 7.2% to 7.8%, as major urban centers in Brazil and Mexico upgrade their clinical testing infrastructures to tackle the increasing prevalence of chronic infectious and metabolic diseases.

Automated Liquid Handling Market Segmentation:        

By Product Type

  • Automated Liquid Handling Workstations
    • Integrated Workstations
    • Standalone Workstations
  • Automated Pipetting Systems
  • Reagent Dispensers
  • Microplate Washers
  • Microplate Readers
  • Other Accessories (Software, Consumables, Grippers)

By Modality                                                                                

  • Disposable Tip Systems
  • Fixed Tip Systems

By Technology

  • Air Displacement Technology
  • Positive Displacement Technology
  • Acoustic Liquid Handling
  • Pressure-based Systems

By Application

  • Drug Discovery and Development
    • High-Throughput Screening
    • Lead Optimization
  • Genomics and Proteomics
    • Next-Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • DNA/RNA Purification
  • Clinical Diagnostics
    • Sample Preparation
    • Immunoassays
  • Cell Biology and Tissue Culture
    • Cell-based Assays
    • Stem Cell Research
  • Biobanking and Bioprocessing

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories
  • Forensic Laboratories

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of MEA
Executive Summary

1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Key Market Trends
1.5. Strategic
Recommendations

Automated Liquid Handling
Introduction

2.1. Market Definition
2.2. Scope of Report
2.3. Methodology
2.4. Assumptions &
Limitations

Automated Liquid Handling
Dynamics

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Challenges

Automated Liquid Handling
Segmentation

4.1. By Types

▪ 4.1.1. Automated Liquid Handling Workstations
▪ 4.1.2. Pipetting Robots
▪ 4.1.3. Dispensers & Burettes
▪ 4.1.4. Accessories & Consumables

4.2. By Applications

▪ 4.2.1. Pharmaceutical & Biotechnology Research
▪ 4.2.2. Clinical Diagnostics
▪ 4.2.3. Genomics & Proteomics
▪ 4.2.4. Drug Discovery & Development
▪ 4.2.5. Academic & Research Institutes

4.3. By Regions

▪ 4.3.1. North America
▪ 4.3.1.1. USA
▪ 4.3.1.2. Canada
▪ 4.3.1.3. Mexico
▪ 4.3.2. Europe
▪ 4.3.2.1. Germany
▪ 4.3.2.2. Great Britain
▪ 4.3.2.3. France
▪ 4.3.2.4. Italy
▪ 4.3.2.5. Spain
▪ 4.3.2.6. Other European Countries
▪ 4.3.3. Asia Pacific
▪ 4.3.3.1. China
▪ 4.3.3.2. India
▪ 4.3.3.3. Japan
▪ 4.3.3.4. South Korea
▪ 4.3.3.5. Australia
▪ 4.3.3.6. Other Asia Pacific Countries
▪ 4.3.4. Latin America
▪ 4.3.4.1. Brazil
▪ 4.3.4.2. Argentina
▪ 4.3.4.3. Other Latin American Countries
▪ 4.3.5. Middle East and Africa
▪ 4.3.5.1. Middle East Countries
▪ 4.3.5.2. African Countries

Regional
Analysis

5.1. North America

▪ 5.1.1. USA
▪ 5.1.1.1. Market Size & Forecast
▪ 5.1.1.2. Key Trends
▪ 5.1.1.3. Competitive Landscape
▪ 5.1.2. Canada
▪ 5.1.2.1. Market Size & Forecast
▪ 5.1.2.2. Key Trends
▪ 5.1.2.3. Competitive Landscape
▪ 5.1.3. Mexico
▪ 5.1.3.1. Market Size & Forecast
▪ 5.1.3.2. Key Trends
▪ 5.1.3.3. Competitive Landscape

5.2. Europe

▪ 5.2.1. Germany
▪ 5.2.1.1. Market Size & Forecast
▪ 5.2.1.2. Key Trends
▪ 5.2.1.3. Competitive Landscape
▪ 5.2.2. Great Britain
▪ 5.2.2.1. Market Size & Forecast
▪ 5.2.2.2. Key Trends
▪ 5.2.2.3. Competitive Landscape
▪ 5.2.3. France
▪ 5.2.3.1. Market Size & Forecast
▪ 5.2.3.2. Key Trends
▪ 5.2.3.3. Competitive Landscape
▪ 5.2.4. Italy
▪ 5.2.4.1. Market Size & Forecast
▪ 5.2.4.2. Key Trends
▪ 5.2.4.3. Competitive Landscape
▪ 5.2.5. Spain
▪ 5.2.5.1. Market Size & Forecast
▪ 5.2.5.2. Key Trends
▪ 5.2.5.3. Competitive Landscape
▪ 5.2.6. Other European Countries
▪ 5.2.6.1. Market Size & Forecast
▪ 5.2.6.2. Key Trends
▪ 5.2.6.3. Competitive Landscape

5.3. Asia Pacific

▪ 5.3.1. China
▪ 5.3.1.1. Market Size & Forecast
▪ 5.3.1.2. Key Trends
▪ 5.3.1.3. Competitive Landscape
▪ 5.3.2. India
▪ 5.3.2.1. Market Size & Forecast
▪ 5.3.2.2. Key Trends
▪ 5.3.2.3. Competitive Landscape
▪ 5.3.3. Japan
▪ 5.3.3.1. Market Size & Forecast
▪ 5.3.3.2. Key Trends
▪ 5.3.3.3. Competitive Landscape
▪ 5.3.4. South Korea
▪ 5.3.4.1. Market Size & Forecast
▪ 5.3.4.2. Key Trends
▪ 5.3.4.3. Competitive Landscape
▪ 5.3.5. Australia
▪ 5.3.5.1. Market Size & Forecast
▪ 5.3.5.2. Key Trends
▪ 5.3.5.3. Competitive Landscape
▪ 5.3.6. Other Asia Pacific Countries
▪ 5.3.6.1. Market Size & Forecast
▪ 5.3.6.2. Key Trends
▪ 5.3.6.3. Competitive Landscape

5.4. Latin America

▪ 5.4.1. Brazil
▪ 5.4.1.1. Market Size & Forecast
▪ 5.4.1.2. Key Trends
▪ 5.4.1.3. Competitive Landscape
▪ 5.4.2. Argentina
▪ 5.4.2.1. Market Size & Forecast
▪ 5.4.2.2. Key Trends
▪ 5.4.2.3. Competitive Landscape
▪ 5.4.3. Other Latin American Countries
▪ 5.4.3.1. Market Size & Forecast
▪ 5.4.3.2. Key Trends
▪ 5.4.3.3. Competitive Landscape

5.5. Middle East & Africa

▪ 5.5.1. Middle East Countries
▪ 5.5.1.1. Market Size & Forecast
▪ 5.5.1.2. Key Trends
▪ 5.5.1.3. Competitive Landscape
▪ 5.5.2. African Countries
▪ 5.5.2.1. Market Size & Forecast
▪ 5.5.2.2. Key Trends
▪ 5.5.2.3. Competitive Landscape

Competitive
Landscape

6.1. Market Share Analysis

6.2. Company Profiles

▪ 6.2.1. Thermo Fisher Scientific Inc. (USA)
▪ 6.2.2. Agilent Technologies Inc. (USA)
▪ 6.2.3. PerkinElmer Inc. (USA)
▪ 6.2.4. Danaher Corporation (USA)
▪ 6.2.5. Tecan Group Ltd. (Switzerland)
▪ 6.2.6. Hamilton Company (USA)
▪ 6.2.7. Eppendorf AG (Germany)
▪ 6.2.8. Beckman Coulter Inc. (USA)
▪ 6.2.9. Sartorius AG (Germany)
▪ 6.2.10. Bio-Rad Laboratories Inc. (USA)

6.3. Strategic Initiatives

Automated Liquid Handling
Outlook and Future Forecast

7.1. Forecast Analysis
7.2. Market Opportunities
7.3. Future Trends
7.4. Investment Analysis

Appendix

8.1. Research Methodology
8.2. Data Sources
8.3. Abbreviations
8.4. Assumptions
8.5. Disclaimer

List of Tables

Table 1: Market Segmentation by Segment 1

Table 2: Market Segmentation by Segment 2

Table 3: Market Segmentation by Segment 3

Table 4: Market Segmentation by Segment 4

Table 5: North America Market Size & Forecast

Table 6: Europe Market Size & Forecast

Table 7: Asia Pacific Market Size & Forecast

Table 8: Latin America Market Size & Forecast

Table 9: Middle East & Africa Market Size & Forecast

Table 10: Competitive Landscape Overview

List of Figures

Figure 1: Global Market Dynamics

Figure 2: Segment 1 Market Share

Figure 3: Segment 2 Market Share

Figure 4: Segment 3 Market Share

Figure 5: Segment 4 Market Share

Figure 6: North America Market Distribution

Figure 7: United States Market Trends

Figure 8: Canada Market Trends

Figure 9: Mexico Market Trends

Figure 10: Western Europe Market Distribution

Figure 11: United Kingdom Market Trends

Figure 12: France Market Trends

Figure 13: Germany Market Trends

Figure 14: Italy Market Trends

Figure 15: Eastern Europe Market Distribution

Figure 16: Asia Pacific Market Distribution

Figure 17: China Market Dynamics

Figure 18: India Market Dynamics

Figure 19: Japan Market Dynamics

Figure 20: South Korea Market Dynamics

Figure 21: Australia Market Dynamics

Figure 22: Latin America Market Distribution

Figure 23: Brazil Market Dynamics

Figure 24: Argentina Market Dynamics

Figure 25: Middle East & Africa Market Distribution

Figure 26: Competitive Landscape Overview

Figure 27: Company A Market Share

Figure 28: Company B Market Share

Figure 29: Company C Market Share

Figure 30: Company D Market Share

FAQ'S

The market was valued at USD 1.34 Billion in 2025 and is projected to reach USD 3.08 Billion by 2033.

The market is expected to grow at a CAGR of 8% from 2025 to 2033.

GBC Scientific Equipment, GERSTEL GmbH & Co. KG, GE Healthcare Life Sciences, Gilson, Hamilton Company, Hitachi, iChrom, PerkinElmer Inc., Thermo Fisher Scientific, SPT Labtech, Shimadzu Scientific, QIAGEN NV., Agilent, Anton-Paar, Analytik Jena, Aurora Biomed, Elemental Scientific, Distek, Ellutia, Fritsch International, EST Analytical

Related Products

Download Sample Report






    For Business Inquiry Fill the Form

      ×

      Download Sample